about
Totipotency, pluripotency and nuclear reprogrammingEthical issues in stem cell research.Responsible oversight of human stem cell research: the California Institute for Regenerative Medicine's medical and ethical standards.Stem cell trials for cardiovascular medicine: ethical rationale.Human embryonic stem cell research, justice, and the problem of unequal biological access.Current progress with primate embryonic stem cellsThe role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditionsFirst-in-human trial participants: not a vulnerable population, but vulnerable nonetheless.Translational research and therapeutic applications of stem cell transplantation in periodontal regenerative medicine.Adapting Preclinical Benchmarks for First-in-Human Trials of Human Embryonic Stem Cell-Based Therapies.Long-term in vitro expansion of human adipose-derived stem cells showed low risk of tumourigenicity.Risk of tumorigenesis in first-in-human trials of embryonic stem cell neural derivatives: Ethics in the face of long-term uncertaintyClinically Driven Safety Benchmarks
P2860
Q24646675-7F24569B-639E-4544-A360-E96197886A17Q30489527-BEF0CC3A-4AE2-4855-A2F9-18C4B0F03A22Q33284045-ADC6390B-4315-4976-9D94-9ED66C913120Q34331206-5D647EA8-617B-4F5E-97F5-EA328296E028Q36942622-9ACD9814-CBC0-4F4E-8590-6846B9469664Q37066438-E4D36DDC-2203-4A24-BB88-F4AA1ABD5EFCQ37193794-6ADABCDB-47EF-476F-ABC1-574457ACCB36Q37217591-FC38E58C-6719-4027-BF78-A7E946979CEAQ38048961-EFE5BE92-F08A-46C7-BA56-EF86D248B7B3Q38873789-88A1ACBC-5594-4B1E-9B41-BEEB0362D8ECQ47817854-C9153A69-B512-42ED-B7A3-6FE1F59B68D7Q56781809-8418FF66-EAD6-429C-81B8-A71FD5096712Q58106729-7F4E4A44-7D02-48F3-AD5E-2676E3BAF692
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Safety issues in cell-based intervention trials.
@ast
Safety issues in cell-based intervention trials.
@en
type
label
Safety issues in cell-based intervention trials.
@ast
Safety issues in cell-based intervention trials.
@en
prefLabel
Safety issues in cell-based intervention trials.
@ast
Safety issues in cell-based intervention trials.
@en
P2093
P50
P1476
Safety issues in cell-based intervention trials.
@en
P2093
Andrew Siegel
Aravinda Chakravarti
Dan W Brock
David H Sachs
Dawn Mueller Agnew
Hilary Bok
John D Gearhart
Kathryn E Schill
LeRoy B Walters
Liza Dawson
P304
P356
10.1016/S0015-0282(03)02218-0
P407
P577
2003-11-01T00:00:00Z